McKinney’s StatLab Medical Products Launches New Manufacturing Facility in Arlington

StatLab said its 2022 acquisition of Wales-based CellPath Ltd.—known for injection molding manufacturing of histology supplies—served as a catalyst for its new, 35,000-square-foot facility in Arlington.

StatLab Medical Products, a McKinney-based global developer and manufacturer of medical diagnostic equipment and supplies, has begun injection molding manufacturing at a new histology consumable manufacturing facility in Arlington.

The company said the facility represents a new era of innovation and transformational opportunity for StatLab, with a new essential manufacturing capability for histology solutions now actively operating in the United States.

StatLab said its 2022 acquisition of Wales-based CellPath Ltd., known for injection molding manufacturing of histology supplies, served as a catalyst for this expansion. Other planned capability expansions at the Arlington site include blow molding as well as glass slide manufacturing, the company said.

StatLab CEO Sung-Dae Hong

“As we expand sales of PiSmart Cassette printers here in the U.S. market, giving customers confidence in a readily available supply of the consumable cassettes used with the printer is imperative,” StatLab CEO Dae Hong said in a statement. “None of this would have been possible without the help of our Newtown, Wales operational and technical teams to support this key capability expansion. We are grateful for their collaboration and partnership to build on their experience spanning more than 30 years with high-quality precision injection molding.”

StatLab now has six facilities across the U.S., United Kingdom, and Germany

The addition of the Arlington plant expands the StatLab in-house manufacturing network to a total of six locations across the United States, United Kingdom, and Germany, making the supply chain shorter, more reliable, and more effective, according to the company, which was founded in 1976.

Injection molding at the 35,000-square-foot facility in Arlington will give laboratories the confidence of additional core histology consumables produced by StatLab in the U.S., the company said. The facility has room for further expansion, StatLab said.

The company said that onsite injection molding capabilities support not only histology cassette manufacturing but also additional components and packaging materials to further reduce the carbon footprint of products, reduce costs, and empower more value for customers while offering more control over the product development ecosystem and supply chain.

StatLab said its new manufacturing capabilities provide flexibility to meet market needs while expanding the company’s portfolio of manufactured cassettes to include a wide variety of styles compatible not only with the PiSmart printer, but also with other on-market printers as well as for manual use.

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.  

R E A D   N E X T

  • StatLab Medical Products, a McKinney-based developer and manufacturer of medical diagnostic supplies, is launching a new manufacturing facility in Arlington after acquiring two UK-based histology consumables and diagnostic equipment companies in 2021 and 2022. Injection molding operations at the new 35,000-square-foot Arlington facility will give laboratories the confidence of additional U.S.-produced core histology consumables including cassettes, the company said. The company also said that at the StatLab Wales campus housing CellPath operations, a lease has been signed and build-out of a 33,000-square-foot building is underway to support additional manufacturing capacity and provide expanded space for the CellNass sample archiving service.…

  • A next-generation technology called "rotating detonation rocket engines" is turning up new possibilities that could advance in-space propulsion to the Moon and beyond. Here's how a team at UT Arlington aims to help the mission.

  • With the help of the U.S. Department of Energy grant, the city of Arlington said it will conduct an innovative pilot program to test the efficiency and scalability of using autonomous, electric drone and robot delivery vehicles. The goal: Reduce greenhouse gas emissions while serving residents in need.

  • Crossing the street shouldn't be a life-or-death activity, but it often is. Nearly 7,500 pedestrians were killed in 2021, the most in four decades. To test a way to save lives, UTA's research team has deployed the Helius Smart Lidar System at two North Texas intersections, using real-time 3D object detection and tracking to analyze pedestrian behavior. They've also deployed a dynamic flashing yellow arrow system that can change the way traffic lights work when pedestrians are detected.

  • Electrical Engineering Professor Yan Wan has received $800,000 in National Science Foundation funding to develop an open-networked airborne computing platform for drones used by first responders. Networking a system of "robots in the air" can help find disaster victims, guide rescuers, and more. Her work could also be used for drone delivery and other commercial applications, UTA says.